当前位置：
X-MOL 学术
›
Microcirculation
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease.
Microcirculation ( IF 1.9 ) Pub Date : 2020-01-14 , DOI: 10.1111/micc.12603 Evelyn Nunes Goulart da Silva Pereira 1 , Raquel Rangel Silvares 1 , Edgar Eduardo Ilaquita Flores 1 , Karine Lino Rodrigues 1 , Anissa Daliry 1
Microcirculation ( IF 1.9 ) Pub Date : 2020-01-14 , DOI: 10.1111/micc.12603 Evelyn Nunes Goulart da Silva Pereira 1 , Raquel Rangel Silvares 1 , Edgar Eduardo Ilaquita Flores 1 , Karine Lino Rodrigues 1 , Anissa Daliry 1
Affiliation
We investigated the protective effects of pyridoxamine against metabolic and microcirculatory complications in nonalcoholic fatty liver disease.
中文翻译：
吡rid醇可改善与非酒精性脂肪肝相关的代谢和微循环并发症。
我们调查了吡ido胺对非酒精性脂肪肝疾病中代谢和微循环并发症的保护作用。
更新日期：2020-01-14
中文翻译：
吡rid醇可改善与非酒精性脂肪肝相关的代谢和微循环并发症。
我们调查了吡ido胺对非酒精性脂肪肝疾病中代谢和微循环并发症的保护作用。
京公网安备 11010802027423号